A model to predict survival in patients with end–stage liver disease
PS Kamath, RH Wiesner, M Malinchoc, W Kremers… - Hepatology, 2001 - journals.lww.com
A recent mandate emphasizes severity of liver disease to determine priorities in allocating
organs for liver transplantation and necessitates a disease severity index based on …
organs for liver transplantation and necessitates a disease severity index based on …
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
G D'Amico, G Garcia-Tsao… - Journal of …, 2006 - journal-of-hepatology.eu
1. Background Liver transplantation significantly improves the survival and quality of life of
patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die …
patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die …
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
KG Saag, GG Teng, NM Patkar… - Arthritis Care & …, 2008 - Wiley Online Library
Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice …
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice …
Compensated cirrhosis: natural history and prognostic factors
P Ginés, E Quintero, V Arroyo, J Terés, M Bruguera… - Hepatology, 1987 - journals.lww.com
To investigate the natural history of compensated cirrhosis, 293 consecutive patients without
previous major complications (ascites, jaundice, encephalopathy or gastrointestinal …
previous major complications (ascites, jaundice, encephalopathy or gastrointestinal …
Hepatic toxicity resulting from cancer treatment
TS Lawrence, JM Robertson, MS Anscher… - International Journal of …, 1995 - Elsevier
Radiation-induced liver disease (RILD), often called radiation hepatitis, is a syndrome
characterized by the development of anicteric ascites approximately 2 weeks to 4 months …
characterized by the development of anicteric ascites approximately 2 weeks to 4 months …
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy
S Terai, T Ishikawa, K Omori, K Aoyama… - Stem …, 2006 - academic.oup.com
We here report nine liver cirrhosis (LC) patients that underwent autologous bone marrow
cell infusion (ABMI) from the peripheral vein. Subjects were patients with LC with total …
cell infusion (ABMI) from the peripheral vein. Subjects were patients with LC with total …
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
Y Muto, S Sato, A Watanabe, H Moriwaki… - Clinical …, 2005 - Elsevier
Background & Aims: Nutritional intervention with branched-chain amino acid (BCAA) is
reported to increase serum albumin concentration in patients with decompensated cirrhosis …
reported to increase serum albumin concentration in patients with decompensated cirrhosis …
Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test
H Imamura, K Sano, Y Sugawara, N Kokudo… - Journal of hepato-biliary …, 2005 - Springer
Preoperative assessment of liver function and prediction of postoperative remaining
functional liver parenchymal mass and reserve is of paramount importance to minimize …
functional liver parenchymal mass and reserve is of paramount importance to minimize …
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
FE De Jongh, HLA Janssen, A Robert, WCJ Hop… - Gastroenterology, 1992 - Elsevier
To evaluate indications for new therapies such as liver transplantation and antiviral therapy,
survival of histologically proven hepatitis B surface antigen (HBsAg)-positive cirrhosis of the …
survival of histologically proven hepatitis B surface antigen (HBsAg)-positive cirrhosis of the …